Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if intensive chemotherapy (with
monoclonal antibody therapy in some patients) given for 8 courses over 5 to 6 months followed
by monthly maintenance chemotherapy for 2 ½ years can improve or cure acute lymphoblastic
leukemia (ALL) or lymphoblastic lymphoma.